CA2141879A1 - Composition inhibitrice a base d'anhydrase carbonique, utilisee comme topique - Google Patents

Composition inhibitrice a base d'anhydrase carbonique, utilisee comme topique

Info

Publication number
CA2141879A1
CA2141879A1 CA002141879A CA2141879A CA2141879A1 CA 2141879 A1 CA2141879 A1 CA 2141879A1 CA 002141879 A CA002141879 A CA 002141879A CA 2141879 A CA2141879 A CA 2141879A CA 2141879 A1 CA2141879 A1 CA 2141879A1
Authority
CA
Canada
Prior art keywords
carbonic anhydrase
anhydrase inhibitor
composition
sulfonamide
dioxide
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
CA002141879A
Other languages
English (en)
Inventor
Thomas Robert Dean
Jesse Albert May
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Alcon Vision LLC
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of CA2141879A1 publication Critical patent/CA2141879A1/fr
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/18—Sulfonamides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/38—Heterocyclic compounds having sulfur as a ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Ophthalmology & Optometry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
CA002141879A 1992-09-17 1993-02-18 Composition inhibitrice a base d'anhydrase carbonique, utilisee comme topique Abandoned CA2141879A1 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US94650892A 1992-09-17 1992-09-17
US07/946,508 1992-09-17

Publications (1)

Publication Number Publication Date
CA2141879A1 true CA2141879A1 (fr) 1994-03-31

Family

ID=25484578

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002141879A Abandoned CA2141879A1 (fr) 1992-09-17 1993-02-18 Composition inhibitrice a base d'anhydrase carbonique, utilisee comme topique

Country Status (5)

Country Link
EP (1) EP0660703A1 (fr)
JP (1) JPH08501303A (fr)
AU (1) AU3722793A (fr)
CA (1) CA2141879A1 (fr)
WO (1) WO1994006411A1 (fr)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2754712B1 (fr) 1996-10-17 1999-09-03 Merck Sharp Dohme Chibret Lab Compositions ophtalmiques
WO2015110993A1 (fr) * 2014-01-24 2015-07-30 Sentiss Pharma Private Limited Composition pharmaceutique comprenant du brinzolamide

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5153192A (en) * 1990-04-09 1992-10-06 Alcon Laboratories, Inc. Thiophene sulfonamides useful as carbonic anhydrase inhibitors
IE911192A1 (en) * 1990-04-12 1991-10-23 Merck & Co Inc Substituted aromatic sulfonamides as antiglaucoma agents
US5157129A (en) * 1990-04-18 1992-10-20 Merck & Co., Inc. Enantiospecific synthesis of s-(+)-5,6-dihydro-4-(r-amino)-4h-thieno(2,3-b)thiopyran-2-sulfonamide-7,7-dioxide
US5091409A (en) * 1990-05-17 1992-02-25 Merck & Co., Inc. 4-alkylamino-6-(C3-5 -hydrocarbyl)thieno[2,3-B]thiopyran-2-sulfonamide-7,7-dioxides
US5093332A (en) * 1990-10-01 1992-03-03 Merck & Co., Inc. Substituted thieno(2,3-b)(1,4)thiazine-6-sulfonamides as antiglaucoma agents
JP2594486B2 (ja) * 1991-01-15 1997-03-26 アルコン ラボラトリーズ インコーポレイテッド 局所的眼薬組成物
US5175284A (en) * 1991-10-15 1992-12-29 Merck & Co., Inc. Tricyclic thienothiopyrans as pharmaceutical intermediates

Also Published As

Publication number Publication date
EP0660703A1 (fr) 1995-07-05
AU3722793A (en) 1994-04-12
WO1994006411A1 (fr) 1994-03-31
JPH08501303A (ja) 1996-02-13

Similar Documents

Publication Publication Date Title
RU2297243C2 (ru) Ингибиторы киназы-3 гликогенсинтазы (gsk-3) для лечения глаукомы
US5180721A (en) Combinations of selective alpha-adrenergic agonists and antagonists useful in lowering intraocular pressure
KR910007530A (ko) 안내압의 감소나 유지를 위한 (2-이미다졸린-2-일 아미노) 퀴녹살린의 사용방법
CA2448317A1 (fr) Methode de traitement du glaucome
KR880011125A (ko) 헤테로 싸이클릭 화합물, 그의 제조방법 및 용도
US5281591A (en) Combinations of selective alpha-adrenergic agonists and antagonists useful in lowering intraocular pressure
US5021410A (en) Combinations of selective alpha-adrenergic agonists and antagonists useful in lowering intraocular pressure
CA2337399A1 (fr) Compositions ophtalmiques pour le traitement de l'hypertension oculaire
US5583150A (en) 5-methyl-isoxazole-4-carboxylic acid anilides and 2-hydroxyethylidene-cyano acetic anilides for the treatment of ocular diseases
IE831933L (en) Derivatives of omega-amino acids
KR100499903B1 (ko) 안압 제어 및 녹내장 치료용 5ｈｔ2 효능제
CA2023560C (fr) Anilides de l'acide 5-methyle-isoxazole-4-carboxylique et anilides de l'acide 2-hydroxyethylidene-cyano acetique pour le traitement des affections oculaires
AU2002346671B2 (en) Aminoalkyl-benzofuran-5-OL compounds for the treatment of glaucoma
CA2291777A1 (fr) Compositions ophtalmiques pour traitement de l'hypertension oculaire
CA2141879A1 (fr) Composition inhibitrice a base d'anhydrase carbonique, utilisee comme topique
KR900015738A (ko) 안압 강하제
KR920701165A (ko) 골수세포형성 촉진에 유용한 헤테로아릴-3-옥소-프로판니트릴 유도체
CZ285129B6 (cs) Oftalmické přípravky, obsahující kombinace inhibitoru karboanhydrasy a beta-adrenergního antagonisty
US6232343B1 (en) Ophthalmic preparations
US5151440A (en) Method for reducing or maintaining intraocular pressure in the mammalian eye by administering pharmaceutical compositions containing 2-(2-alkylphenylamino)-oxazolines, 2-(2-alkylphenyl-amino)-thiazolines and 2-(2-alkylphenylamino)-imidazolines
CA2294343A1 (fr) Procede permettant d'optimiser l'etat de sante de la retine et du nerf optique
US5225424A (en) Methazolamide-derived carbonic anhydrase inhibitors
CA2128324A1 (fr) Traitement du galucome
US5252595A (en) Method for reducing or maintaining intraocular pressure in the mammalian eye by administering pharmaceutical compositions containing 2-(2-alkylphenylamino)-oxazolines, 2-(2-alkylphenylamino)-thiazolines and 2-(2-alkylphenylamino)-imidazolines
US20060211700A1 (en) (R)-8,9-dichloro-2,3,4,4a-tetrahydro-1H,6H-pyrazino[1,2-a]quinoxalin-5-one for controlling IOP and treating glaucoma

Legal Events

Date Code Title Description
FZDE Dead